ARTICLE | Company News
Boehringer submits Spiriva NDA
December 18, 2001 8:00 AM UTC
Boehringer Ingelheim (Ingelheim, Germany) submitted an NDA to the FDA for its Spiriva once-daily inhaled bronchodilator M3 receptor antagonist to treat chronic obstructive pulmonary disease (COPD). Pf...